News | 15 November 2012
The subscription period for Oasmia Pharmaceutical AB's (publ) ("Oasmia" or the "Company") rights issue ended on November 9, 2012. The final result of the rights issue indicates that 18,405,300 shares, representing approximately 75 per cent of the ...
Click on the link to read the full article at 4-traders
(This link will open in a new window)